News & Updates

Immunosuppression does not raise risk of overall, cancer mortality

01 Dec 2023

Use of immunosuppressants does not appear to increase the incidence of all-cause and cancer mortality in patients with noninfectious ocular inflammatory disease (OID) over a median follow-up of 10 years, a recent study has shown.

Immunosuppression does not raise risk of overall, cancer mortality

01 Dec 2023

Intimacy, sexual needs often unmet among partners of terminal cancer patients

01 Dec 2023

There is an unmet need for some hospitalized patients with terminal cancer to have time for intimacy with their partners that requires attention, suggests a study.

Intimacy, sexual needs often unmet among partners of terminal cancer patients

01 Dec 2023

Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer

29 Nov 2023

Endoscopic ultrasound-guided celiac plexus neurolysis added to medical management (EUS-CPN+MM) provides beneficial effects for abdominal pain in patients with unresectable pancreatic cancer at 4 and 12 weeks, reports a recent study.

Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer

29 Nov 2023

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023 by

A systematic review and meta-analysis by researchers from the University of Hong Kong has shown that the use of peripherally inserted central catheters (PICCs) is associated with a higher rate of complications than central lines in terminally ill cancer patients with central venous access devices (CVADs) for palliative care. No conclusions were reached regarding the use of totally implanted ports (PORTs), as no studies on PORTs were eligible for analysis.

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

27 Nov 2023

In the treatment of older patients with metastatic castration-resistant prostate cancer (mCRPC) who are considered unsuitable candidates for standard cabazitaxel (CBZ) regimens, treatment with CBZ at 16 mg/m2 (biweekly CBZ16) plus prophylactic granulocyte colony–stimulating factor (G-CSF) at each cycle helps reduce the risk of higher grade neutropenia and/or neutropenic complications while yielding similar clinical outcomes, according to the results of the phase III CABASTY trial.

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

27 Nov 2023

Community pharmacists lack readiness to manage oral anticancer medicines

25 Nov 2023

Community pharmacists appear to be lacking in both knowledge and willingness to properly handle the use of oral anticancer medicines (OAMs), according to a Qatar study.

Community pharmacists lack readiness to manage oral anticancer medicines

25 Nov 2023

Acupuncture, massage equally effective for cancer pain

24 Nov 2023 by

In patients with advanced cancer, both acupuncture and massage prove beneficial in reducing pain and fatigue, as well as improving insomnia symptoms and quality of life, as shown in the IMPACT trial.

Acupuncture, massage equally effective for cancer pain

24 Nov 2023

Tacrolimus levels monitoring needed when initiating letermovir, says study

24 Nov 2023

Patients receiving the combination of letermovir and tacrolimus with concomitant moderate cytochrome P450 (CYP) 3A4 inhibitors show a decline in tacrolimus dosing requirements, a study has shown.

Tacrolimus levels monitoring needed when initiating letermovir, says study

24 Nov 2023

Outpatient initiation of venetoclax safe, feasible in acute myeloid leukaemia

24 Nov 2023

Initiation of venetoclax for acute myeloid leukaemia (AML) in the outpatient setting with a pharmacist-led interdisciplinary protocol is both feasible and safe, reports a study.

Outpatient initiation of venetoclax safe, feasible in acute myeloid leukaemia

24 Nov 2023

Thromboembolism rate lower than expected in Chinese patients with pancreatic cancer

22 Nov 2023 by

Chinese patients with pancreatic cancer have a lower incidence of thromboembolism compared with Western populations, and thromboembolism does not affect overall survival (OS), researchers from the Chinese University of Hong Kong (CUHK) have reported.

Thromboembolism rate lower than expected in Chinese patients with pancreatic cancer

22 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Immunosuppression does not raise risk of overall, cancer mortality

Immunosuppression does not raise risk of overall, cancer mortality

Intimacy, sexual needs often unmet among partners of terminal cancer patients

Intimacy, sexual needs often unmet among partners of terminal cancer patients

Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer

Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

Community pharmacists lack readiness to manage oral anticancer medicines

Community pharmacists lack readiness to manage oral anticancer medicines

Acupuncture, massage equally effective for cancer pain

Acupuncture, massage equally effective for cancer pain

Tacrolimus levels monitoring needed when initiating letermovir, says study

Tacrolimus levels monitoring needed when initiating letermovir, says study

Outpatient initiation of venetoclax safe, feasible in acute myeloid leukaemia

Outpatient initiation of venetoclax safe, feasible in acute myeloid leukaemia

Thromboembolism rate lower than expected in Chinese patients with pancreatic cancer

Thromboembolism rate lower than expected in Chinese patients with pancreatic cancer